Biotech Content Business | ~75% Net Margins

Asking Price$50,000

Cash Flow

EBITDA$12,524

Gross Revenue$16,664

InventoryNot Disclosed

FF&ENot Disclosed

Real EstateNot Disclosed

listing imageSave

Biotech Content Business | ~75% Net Margins


Asking Price$50,000

Cash Flow

EBITDA$12,524

Gross Revenue$16,664

InventoryNot Disclosed

FF&ENot Disclosed

Real EstateNot Disclosed

Business Description
Strong Growth with Untapped Upside
This listing is a profitable biotech-focused content business serving a premium audience of biotech investors, scientists, and healthcare professionals.

Built organically since 2021, the platform has developed strong credibility and trust, reaching nearly 22,000 followers on X and 3,400 Substack subscribers (including about 300 paid). The business generates nearly $18,000 in annualized revenue, growing 34% year-over-year, while requiring just 5–10 hours per week to operate, maintaining minimal overhead.

The business is intentionally under-monetized, with revenue driven almost entirely by Substack subscriptions despite consistent inbound interest from advertisers and sponsors. Clear upside exists through sponsorships, premium tiers, institutional partnerships, and expanded content offerings, none of which have been meaningfully tested.

This opportunity is ideal for a biotech-focused investor, individual operator, or media group looking to expand into healthcare verticals. For the right buyer, this is a lean, cash-flowing content asset with strong engagement, loyal readers, and multiple straightforward paths to scale.


Key Benefits:

Established, Trusted Biotech Brand: The brand has strong credibility among biotech investors, scientists, and industry professionals since 2021.

Engaged, Scalable Audience: The audience includes nearly 22,000 X followers and around 3,400 Substack subscribers, grown primarily through organic, content-driven demand.

Profitable and Low-Overhead Operations: The brand generates ~$18K annualized subscription revenue with no employees and only 5–10 hours per week required.

Proven Retention and Willingness to Pay: High subscriber retention and a paid audience validate product-market fit for premium biotech content.

Significant Monetization Upside: Monetization has historically been conservative, with clear expansion paths in sponsorships, premium research, and educational products.

Simple, Transferable Operating Model: The brand has an easy-to-run tech stack (Substack, X, Stripe) with a repeatable, teachable content framework.

Founder Transition Support Available: The seller is willing to provide a structured handoff, editorial guidance, and limited post-close advisory support.
About the Business
Years in Operation
5
Currently Relocatable
Yes
Currently Home Based
Yes
Market Outlook / Competition
The business only has potential competition from institutional research.
Opportunities for Growth
Growth opportunities include expanding paid tiers, institutional sponsorships, educational products, and premium research reports.
About the Sale
Seller Motivation
The seller is transitioning roles and lacks time for running the business.
Transition Support
The seller is willing to provide a structured handoff, editorial guidance, and limited post-close advisory support.
Listing Info
ID
2456658
Listing Views

Contact Seller

By clicking the button, you agree to BizQuest's Terms of Use and Privacy Notice.

Business Listed by: Quiet Light Quiet Light Brokerage, Inc.

Listing ID: 2456658 The information on this listing has been provided by either the seller or a business broker representing the seller. BizQuest has no interest or stake in the sale of this business and has not verified any of the information and assumes no responsibility for its accuracy, veracity, or completeness. See our full Terms of Use. Learn how to avoid scams.


Similar Listings
CMIT Solutions
$100,000CMIT SolutionsFeatured Franchise